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Objective: Postpneumonectomy syndrome is a rare syndrome of dynamic airway
obstruction caused by extreme rotation and shift of the mediastinum after pneumonec-
tomy, resulting in symptomatic central airway compression. We have treated this syn-
drome by mediastinal repositioning and placement of saline-filled prostheses into the
pneumonectomy space. There is a paucity of outcome data for patients treated surgi-
cally, with only a single series of 11 patients previously reported. We analyzed our
recent experience with treatment of this syndrome and report on the short and long-
term outcomes and quality of life assessment of the largest series ever reported of
patients treated by mediastinal repositioning.
Methods: Records were reviewed of all patients who underwent mediastinal reposi-
tioning for postpneumonectomy syndrome between January of 1992 and June of
2006. Long-term health-related quality of life was assessed by administration of the
Saint George’s Respiratory Questionnaire.
Results: There were 18 patients (15 women and 3 men) with a median age of 44
years (range 14–67 years). Thirteen patients had undergone right pneumonectomy,
and 5 patients had undergone left pneumonectomy. None of the patients in whom
postpneumonectomy syndrome developed after left pneumonectomy had a right-
sided aortic arch. Five patients had undergone pneumonectomy in childhood
(age , 13 years). The median interval between pneumonectomy and mediastinal
repositioning was 7.5 years (range 1.1–54.8 years). The median follow-up was
32 months (range 4–143 months). The operative mortality was 5.6% (1/18). Com-
plications occurred in 5 patients (27.8%): pneumonia in 3 patients and acute respi-
ratory distress syndrome in 2 patients. The median hospitalization was 6 days
(range 3–155 days). Some 77% (10/13) of patients reported significant improve-
ment in their breathing and overall state of health after surgery; 15.4% of patients
(2/13) were somewhat better, and 7.7% of patients (1/13) had no improvement. No
patients’ condition was worse after surgery. All patients who reported improvement
in their symptoms after surgery remained symptomatically improved at the time of
the quality of life assessment. Some 92.3% (12/13) were not at all or only slightly
limited in their social activities because of breathing problems, and 84.6% (11/13)
were not at all or only slightly limited in their ability to work as a result of their
physical health.
Conclusion: Repositioning of the mediastinum with placement of prostheses for post-
pneumonectomy syndrome can be performed with low mortality and morbidity. Sur-
gical repositioning provides immediate and lasting symptomatic relief to patients in
whom postpneumonectomy syndrome develops.
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TSAbbreviations and Acronyms
COPD 5 chronic obstructive pulmonary disease
FEV1 5 forced expiratory volume in 1 second
FVC 5 forced vital capacity
PEFR 5 peak expiratory flow rate
QOL 5 quality of life
SF-12 5 short-form health survey [12 items]
SGRQ 5 Saint George’s Respiratory Questionnaire
P
ostpneumonectomy syndrome is a rare condition that
occurs in children or adults after a pneumonectomy.
For reasons that remain poorly understood, in certain
patients, the heart and mediastinum shift excessively toward
the side of the pneumonectomy and the great vessels also ro-
tate significantly. Herniation of the remaining lung with over-
distension accompanies this shift and rotation. After either
right or left pneumonectomy, the remaining distal trachea
and/or main bronchus can become compressed against the
vertebral column or aorta by the pulmonary artery. This re-
sults in severely symptomatic central airway compression
and dynamic airway obstruction (Figure 1).
In 1992 we reported on our experience with the diagnosis
and management of 11 adults with severe symptoms from
postpneumonectomy syndrome.1 On the basis of lessons
learned during this initial experience, we have surgically
treated all subsequent patients with postpneumonectomy
syndrome with mediastinal repositioning and placement of
breast prostheses into the pneumonectomy space to prevent
recurrences. By restoring the normal anatomic relationships
and allowing the compressed airway to return to its normal
position and patency, mediastinal repositioning relieves the
mechanical obstruction of the bronchial tree in those patients
in whom malacia has not developed and also corrects over-
distension of the herniated and hyperexpanded lung.
There remains a paucity of outcome data on patients with
postpneumonectomy syndrome treated surgically. Since our
original report, only a collection of small case reports have
been reported. The purpose of this study was to evaluate
and analyze our recent experience with treatment of this
syndrome and report on the short and long-term outcomes
and quality of life (QOL) assessment of patients treated
with mediastinal repositioning.
Materials and Methods
All patients who were evaluated and treated surgically for postpneu-
monectomy syndrome at our institution between January of 1992
and June of 2006 were identified from a prospectively maintained
surgical database. The institutional review board at Partners Health-
care and Massachusetts General Hospital approved this study, and
all patients were contacted and agreed to participate in the QOL as-
sessment. The medical records of these patients were reviewed for
patient demographics, presenting signs and symptoms, surgical ap-
proach, date of surgery, interval between the pneumonectomy andThe Journal of Thorathe development of postpneumonectomy syndrome, preoperative
and postoperative radiographic and pulmonary function studies,
postoperative morbidity and mortality, length of hospitalization,
and last follow-up visit or date of death. Because patients came
from a wide geographic referral area, follow-up was necessarily car-
ried out by patient questionnaire and with the cooperation of the re-
ferring physicians. Long-term QOL was assessed by a self-
administered questionnaire on general QOL, the short-form health
survey [12 items] (SF-12), and a health-related QOL questionnaire,
the Saint George’s Respiratory Questionnaire (SGRQ). The SF-12 is
a comprehensive general QOL assessment tool based on the short-
form health survey [36 items], which has been validated in more
than 2000 publications to be useful in monitoring general and
specific populations, comparing the burden of different diseases,
and differentiating the health benefits produced by different treat-
ments. The SGRQ is the most widely used disease-specific health
status questionnaire used to measure health impairment in patients
with chronic obstructive respiratory diseases, such as asthma and
chronic obstructive pulmonary disease (COPD). It is a self-adminis-
tered 51-item survey encompassing 3 components: symptoms,
activity, and social or psychologic impacts. Scores range from
0 (best score) to 100 (worst score), and a change of 4 units has
been shown to be clinically significant.
Results
Patient details are listed in Table 1. Eighteen patients were
evaluated and treated surgically for postpneumonectomy syn-
drome. Fifteen patients were female (83.3%), and 3 patients
were male (16.7%). The syndrome developed after right
pneumonectomy in 13 patients and after left pneumonectomy
in 5 patients. None of the patients in whom the syndrome de-
veloped after left pneumonectomy had a right aortic arch. All
patients had symptoms of progressive and incapacitating
dyspnea that occurred with minimal effort and that occurred
at rest in the most severely affected patients. Other presenting
symptoms were audible stridor or wheezing (56%), recurrent
infections (33%), cough (22%), gastroesophageal reflux
(11%), hemoptysis (11%), chest pain (5%), and dysphagia
(5.6%). The median age at the time of attempted correction
was 44 years, with a range of 14 to 67 years. The median in-
terval between the original pneumonectomy and the time of
attempted correction was 7.5 years, with a range from 1.1 to
54.8 years. Five patients had undergone pneumonectomy in
childhood (age , 13 years). Two patients had undergone
prior operative procedures to reposition the mediastinum
and required redo surgery. One patient had developed recur-
rent symptoms 4 years after her original repositioning opera-
tion, which had included placement of a breast prosthesis in
the pneumonectomy space. Two subsequent attempts to repo-
sition her mediastinum had failed to resolve her airway ob-
struction, and she had become ventilator dependent. In an
attempt to liberate her from mechanical ventilation, she un-
derwent aortic division with bypass from the ascending aorta
to the descending aorta with a graft. She developed hemody-
namic instability postoperatively and died of multisystemcic and Cardiovascular Surgery c Volume 135, Number 6 1211
General Thoracic Surgery Shen et al
G
TSTABLE 1. Patient details
Patient
Age at time of
repositioning Sex
Indication for
pneumonectomy
Pneumonectomy
side
Interval between
original and
corrective surgery (y)
Follow up
interval
(mo)
No. of
implants
Volume
of implants
(mL)
Hospital
length
of stay (d)
1 41 F Carcinoid R 7.7 5.2 2 1000 155
2 46 M Bronchiectasis L 39.3 143 3 1205 6
3 46 F Broncholithiasis R 4.3 140.8 2 1000 11
4 26 F Granular cell tumor L 14.2 100 2 620 11
5 14 M Bronchiectasis R 1.2 97 3 1500 9
6 33 F Infected cyst R 33.5 31 4 1610 41
7 55 F Lung cancer L 8.1 60 3 780 6
8 28 F Congenital hypoplasia R 2.3 48 2 800 5
9 60 F Lung abscess R 54.8 51 2 300 3
10 31 F Lung cancer R 1.1 40 1 750 5
11 39 F Congenital bronchial
anomaly
R 1.1 32 2 1060 5
12 57 F Lung cancer R 1.2 12 2 810 5
13 60 F Lung cancer L 7.9 14 3 1050 66
14 49 F Lung cancer R 2.4 13 2 850 5
15 67 F Broncholithiasis L 18 13 2 575 5
16 20 F Carcinoid R 4.6 4 2 650 6
17 35 F Trauma R 7.3 8 1 225 31
18 65 M Lung cancer R 8.0 30 2 530 150organ failure on postoperative day 2. The second patient was
a 20-year-old woman who developed recurrent postpneumo-
nectomy syndrome 1 year after her original mediastinal repo-
sitioning operation when one of her saline-filled breast
implants spontaneously ruptured. She subsequently had Lu-
cite balls placed into the pneumonectomy space, which did
not relieve the symptoms (Figures E1 and E2). She was
then referred to our institution, and at her third operation,
we removed all of the Lucite balls and repositioned her medi-
astinum with saline-filled breast implants (Figures E3 and
E4). She remains well and fully active 4 years after this pro-
cedure and recently gave birth to a child. The indication for
pneumonectomy was neoplastic disease in 9 patients, chronic
infection in 4 patients, congential lung disease in 2 patients,
broncholithiasis in 2 patients, and trauma in 1 patient.
Surgical Management
The mediastinum was repositioned in all 18 patients by
reopening the side of the original pneumonectomy and lysing
scar and adhesions sufficiently to allow the heart and medias-
tinal structures to be repositioned in a central position and the
herniated lung to be reduced to the opposite side. An impor-
tant technical point to emphasize is that the junction between
the pneumonectomy stump and the main bronchus needs to
be extensively dissected and liberated. That junction is often-
times scarred to either the vertebral body or the posterior me-
diastinum, and complete liberation and lysis of the scar tissue
there are essential. Otherwise, it is possible to reposition the
mediastinal structures centrally, but if that tethering point has
not been fully dissected, there will still be mechanical com-1212 The Journal of Thoracic and Cardiovascular Surgery c Jpression of either the main or lobar bronchi, and the desired
result will not be achieved. In 9 patients, the pericardium was
also sutured to the fascia of the undersurface of the sternum
with 2 vertical rows of 0 Prolene (Ethicon, Somerville, NJ)
sutures. Care was taken not to produce tamponade by
Figure 1. Representative preoperative bronchoscopic appearance
of the trachea and left main bronchus in postpneumonectomy syn-
drome after a right pneumonectomy.une 2008
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reefing up too much pericardium. Careful monitoring of the
patients’ hemodynamics with a central venous line and arte-
rial line was essential during this phase of the procedure.
The pneumonectomy space was filled with saline-filled
breast prostheses in all 18 patients. The number and volume
of prostheses were selected, which was sufficient to fill the
pneumonectomy space returning the heart and mediastinum
to a central position without compressing the heart and
remaining lung. The volume necessary to reposition the me-
diastinum is determined by instilling a measured amount of
saline into the pneumonectomy space. The median number
of implants used was 2 (range 1–4). The median volume of
prostheses placed was 805 mL (range 225–1610 mL). Intra-
operative flexible bronchoscopy to assess the patency and
stability of the airway was performed after repositioning
the mediastinum and after prosthetic placement (Figure 2).
It was also performed once the patients were placed supine
after the completion of the operation. Pulse, blood pressure,
and central venous pressure were carefully monitored during
mediastinal repositioning and prosthetic placement, and once
the patient was placed supine after the chest had been closed
to detect tamponade physiology. An intraoperative chest ra-
diograph was obtained in all patients to assess the mediastinal
position and rule out any significant atelectasis. Sometimes
after the thoracic incision is closed, the prosthetic volume
instilled is too great, producing atelectasis and/or hemody-
namic compromise. This was the case in 4 patients who
had their partially closed incision reopened and the prosthetic
volume reduced. Other than the first patient in the series who
underwent aortic division, none of the subsequent 17 patients
had any significant tracheobronchial malacia after reposition-
ing, and none required placement of airway stents after
surgery.
Our surgical management of this syndrome has evolved
since our original report. Initially, 4 intercostalmuscle bundles
were dropped into the pneumonectomy space to lie against the
pericardium. The anterior and posterior attachments werepreserved, and a strip of periosteum on the anterior surface
of each rib was left to maintain bony integrity. This was
done to provide a firm partition, which would solidify as the
periosteum calcified, and prevent recurrence if the prosthesis
needed to be removed later. This additional step is now thought
to be unnecessary, and none of the patients in this series had
intercostal muscles dropped into the chest. Attempting to affix
the pericardium to the back of the sternum is also no longer
thought to be necessary, and the last 9 patients in this series
did not have this as part of their operative repair.
Hospital Course
There were no intraoperative deaths. One patient died after
surgery, and the operative mortality for the series was 5.6%
(1/18). The cause of death was multisystem organ failure
after aortic division and bypass in a 45-year-old woman
who developed recurrent postpneumonectomy syndrome 4
years after successful mediastinal repositioning with breast
prostheses. The median hospitalization was 6 days (range
3–155 days). Complications occurred in 5 patients (27.8%).
Pneumonia developed in 3 patients, and acute respiratory
distress syndrome developed in 2 patients.
Long-term Outcomes
Follow-up was complete in all 17 operative survivors. The
median follow-up was 32 months (range 4–143 months).
One patient underwent reoperation to have his implants
removed 1 year after placement because his dyspnea symp-
toms and pulmonary function studies had worsened after
mediastinal repositioning with implants; it was thought that
lobar compression developed as a result of the implants.
His symptoms improved after removal of his implants.
Pulmonary Function Studies
Eleven patients had pulmonary function studies with spirom-
etry performed before and after surgical correction (Table 2).
The vital capacity decreased in all patients from a mean of
2.28 to 1.64 L (P , .05). The forced expiratory volume inFigure 2. A, Preoperative bronchoscopy
in a 39-year-old woman (patient 11) who
developed postpneumonectomy syn-
drome after right pneumonectomy 1
year earlier. The left lower lobe bron-
chus (arrows) has been almost com-
pletely compressed. B, Postoperative
bronchoscopy showing widely patent
lobar orifices.
The Journal of Thoracic and Cardiovascular Surgery c Volume 135, Number 6 1213
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Preoperative testing Postoperative testing
Patient
No.
FEV1 %
predicted
FVC %
predicted
FEV1/FVC %
predicted
PEFR %
predicted
FEV1 %
predicted
FVC %
predicted
FEV1/FVC %
predicted
PEFR %
predicted
2 2.02 54.0% 3.25 71.0% 0.62 75.6% 5.21 57.0% 1.39 38.0% 2.39 53.0% 0.58 64.0% 4.89 54%
3 1.65 60.0% 2.41 74.0% 0.68 85.0% 3.99 65.0% 1.61 59.0% 2.07 59.0% 0.78 99.0% 3.41 54%
4 1.15 43.0% 1.23 41.0% 0.93 104.0% 2.69 49.0% 1.06 38.0% 1.13 36.0% 0.93 106.0% 2.99 53.0%
5 1.65 48.0% 3.3 82.0% 0.50 57.0% 2.47 33.7% 1.45 42.0% 2.22 55.0% 0.65 75.0% 2.58 35.0%
6 1.06 33.0% 1.75 44.0% 0.60 74.0% 2.83 40.3% 0.74 21.0% 0.79 18.0% 0.94 113.0% 3.13 46.0%
8 1.7 52.0% 3.58 94.0% 0.48 55.0% 2.61 38.0% 1.40 41.0% 1.85 46.0% 0.76 89.0% 2.29 34.0%
9 1.17 55.0% 1.14 46.0% 0.88 121.0% 2.58 51.0% 0.43 21.0% 0.54 22.0% 0.80 97.0% 2.78 20.0%
13 1.08 47.0% 2.35 82.0% 0.46 58.0% 2.46 43.0% 0.97 43.0% 1.83 64.0% 0.53 66.0% 2.47 43.0%
16 0.78 23.0% 1.93 50.0% 0.41 47.0% 1.32 18.0% 0.88 27.0% 1.69 45.0% 0.52 48.0% 1.54 23%
17 1.17 38.0% 1.85 50.0% 0.63 76.0% 2.59 39% 0.98 32.0% 1.36 37.0% 0.72 86.0% 2.13 32.0%
18 1.18 30.0% 2.27 45.0% 0.52 68.0% 3.24 35% 1.34 34.0% 2.14 44.0% 0.63 79.0% 3.41 40%
Mean 1 SE 1.33 1 0.11 2.28 1 0.25 0.61 1 0.05 2.91 1 0.30 1.11* 1 0.11 1.64* 1 0.18 0.71* 1 0.04 2.87 1 0.26
FEV1, Forced expiratory volume in 1 second (L); FVC, forced vital capacity (L); PEFR, peak expiratory flow rate (L/sec); SE, standard error. *P , .05 versus
preoperative value.1 second (FEV1) decreased in 9 patients and improved in 2
patients. The mean decreased from 1.33 to 1.11 L (P, .05).
The FEV1/forced vital capacity (FVC) ratio improved in 8 pa-
tients, was unchanged in 1 patient, and decreased in 2 pa-
tients. The mean increased from 0.61 to 0.71 (P , .05).
Peak expiratory flow rates (PEFRs) improved in 7 patients
and decreased in 4 patients. Postoperative PEFR was not sig-
nificantly different from preoperative values.
Health-related Quality of Life
Thirteen of the 17 operative survivors completed a general
and disease-specific health-related QOL questionnaire. The
median time between the mediastinal repositioning and the
QOL assessment was 32 months (range 4–145 months).
Ten patients (77%) reported significant improvement in their
overall health and breathing after surgery (Table E1). Two
patients (15%) reported somewhat better conditions, 1 patient
(7.7%) reported no improvement, and no patients reported
worse conditions compared with their preoperative status.
All patients who reported improvement in their symptoms af-
ter surgery remained symptomatically improved at the time
of the QOL assessment. Twelve patients (92.3%) were not
at all or only slightly limited in their normal social activities
because of physical or emotional problems related to their
breathing problems. One patient was moderately limited,
and none were severely limited. Eleven patients (84.6%)
were not at all or only slightly limited in their ability to
work or perform other strenuous activities as a result of their
physical health. Two patients (15.4%) were limited in their
ability to work or perform strenuous activity most of the
time. In the month preceding the QOL assessment, 9 patients
(69.2%) reported complete freedom from dyspnea symptoms
or symptoms only a few days per month or only when there
was a pulmonary infection. Two patients (15.4%) still had1214 The Journal of Thoracic and Cardiovascular Surgery c Jupersistent dyspnea symptoms several days per week, and 2
patients (15.4%) had dyspnea symptoms almost every day.
Twelve patients (84.6%) described their lung/respiratory
condition as causing no or few problems. One patient
(7.7%) reported it as the most important problem affecting
overall health. Scores from the SGRQ are shown in Table E2.
Discussion
For reasons that remain unknown, in a small subset of patients
who undergo pneumonectomy, excessive mediastinal shift
and rotation toward the empty hemithorax can occur. This
mediastinal displacement results in airway obstruction that
causes progressive and disabling symptoms. After right pneu-
monectomy, the mediastinum shifts to the right and posteri-
orly with counterclockwise rotation of the heart and great
vessels, as seen on computed tomography scan. After left
pneumonectomy, the mediastinum rotates clockwise. Medi-
astinal shift and rotation are accompanied by herniation and
hyperinflation of the remaining lung. The trachea and main-
stem bronchus are displaced toward the pneumonectomy
space, and the main bronchus becomes compressed between
the left pulmonary artery and vertebral column or descending
aorta in the case of a right pneumonectomy, or between the
right pulmonary artery and vertebral column or aorta in the
case of a left pneumonectomy.
There have been many case reports in the literature
describing postpneumonectomy syndrome in both children
and adults. Although the incidence in adults in unknown,
the syndrome is thought to be more likely to develop in
infants and young children than in adults.2-4 In children,
the incidence has been estimated to be 1 case per 640 pneu-
monectomies.4 Factors that have been proposed to explain
the higher incidence in the younger age group include
increased elasticity and compliance of the remaining lungne 2008
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somatic growth. In our original report, only 2 of 11 patients
had undergone pneumonectomy in childhood. In the present
series, 5 of 18 patients had undergone pneumonectomy in
childhood.
Postpneumonectomy syndrome seems to be more com-
mon after right pneumonectomy.5 Of the 29 patients we
have treated at our institution, 20 developed the syndrome af-
ter right pneumonectomy and 9 developed the syndrome after
left pneumonectomy. We do not have an explanation for this
observation. Given the natural leftward position of the heart,
it is possible that rightward mediastinal shift after right pneu-
monectomy produces more severe anatomic derangement
and is therefore more likely to cause symptoms. Although
we originally believed that the presence of a right aortic
arch was a prerequisite for developing postpneumonectomy
syndrome after left pneumonectomy, it has been shown that
postpneumonectomy syndrome can occur with a left-sided
aortic arch after left pneumonectomy.6-10 In contrast with
our original report, none of the 5 patients who developed
postpneumonectomy syndrome after left pneumonectomy
had a right aortic arch.
A variety ofmethods to attempt surgical correction of post-
pneumonectomy syndrome have been reported. Most consist
of single case reports. Division of the ligamentum
arteriosum6, fixation of the aorta or pulmonary artery to the
sternum,11,12 and placement of expandable metallic stents13
have been reported with varying results. Given the young
age ofmany of these patients and the future possibility of stent
migration, erosion into the pulmonary artery or aorta, and de-
velopment of granulation tissue, long-term results with stent-
ing confirming its safety and efficacy are needed before it can
be recommended as primary treatment for this syndrome.
As our experience with this syndrome has grown, we
believe that surgical correction is best achieved by restoration
of the normal mediastinal position to allow the compressed
airway to return to its normal position and patency. Several
methods for repositioning the mediastinum have also been
described. These include suture fixation of the pericardium
to the back of the sternum,1 surgical and chemical phrenec-
tomy,5 and placement of prostheses to fill the empty
hemithorax. Lucite plastic balls,12 silastic implants,3,14,15
injection of sulfur hexafluoride into the pneumonectomy
space,16 and saline-filled breast prostheses1,7,9,10 have been
used prophylactically and therapeutically. Since our original
report, we have treated all patients with postpneumonectomy
syndrome with mediastinal repositioning and placement of
saline-filled breast prostheses. This method of correction
has also been widely adopted by other groups with
success.7,9,10
In our original report, 4 patients were found to have signif-
icant malacic changes in their airways in addition to shift and
rotation of the mediastinum. Mediastinal repositioning and
fixation by placement of prostheses are insufficient, and theThe Journal of Thoraother procedures we have tried to address the malacic airway
have not been successful. The only operative death in the
current series was 1 patient who developed severe airway
malacia and recurrent symptoms 4 years after mediastinal re-
positioning. Three subsequent attempts to reposition her me-
diastinum were unsuccessful, and she died of complications
after an attempt to relieve her airway compression with aortic
division and bypass. We did not encounter severely malacic
airways in the 17 patients who underwent operation after this
patient. We would recommend that patients who have
malacic airways in addition to mediastinal shift undergo
mediastinal repositioning and stenting of the airway with
a completely covered stent. Kelly and colleagues17 reported
successful management of such a patient using this strategy.
The benefit of repositioning the mediastinum is the result
of relief of the compression of the bronchial tree and correc-
tion of the hyperinflation of the herniated lung. Pulmonary
function studies in the 11 patients who had spirometry avail-
able before and after repositioning showed improvements in
flow rates and a decrease in hyperinflation. All patients
showed a decrease in FVC due to relief of hyperinflation.
In most patients, the decrease in FVC was also greater in
absolute amount than the decrease in FEV1, resulting in an
improvement in the FEV1/FVC ratio. However, in contrast
with the findings of our original report, which showed a con-
sistent improvement in PEFR and an improvement in the
FEV1/FVC ratio in every patient, in this series, PEFR im-
proved in 7 patients and decreased in 4 patients. The im-
provement in PEFR was not statistically significant. In the
only other report in the literature that has reported on pulmo-
nary function tests before and after mediastinal repositioning
for postpneumonectomy syndrome, Valzi and colleagues9 re-
ported a significant increase in the PEFR for all 5 patients in
their series with a mean improvement of 44.2%. The FEV1/
FVC ratio in their patients improved in 3 patients, decreased
in 1 patient, and was unchanged in 1 patient. The mean im-
provement was 13.2%. One possible explanation for the dif-
ference in PEFR findings is that perhaps there was less
tracheal compression in the patients who did not have an im-
provement in PEFR after surgery. Hyperexpansion of the
remaining lung may have been a more significant factor for
these patients, and relief of dyspnea symptoms may have
been due to a decrease in hyperinflation. In the 4 patients
who had a decline in PEFR, the FEV1/FVC ratio improved
in 3. The 1 patient who showed decline in both the FEV1/
FVC ratio and PEFR also had worse symptoms after reposi-
tioning and underwent removal of his implants 1 year later.
His symptoms improved somewhat after removal of the im-
plants.
Studies in patients with COPD have demonstrated that
evaluation of the effectiveness of treatments for COPD
requires the assessment of both clinical and physiologic vari-
ables. In patients with obstructive lung disease with dyspnea
as the primary symptom, spirometric parameters such ascic and Cardiovascular Surgery c Volume 135, Number 6 1215
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ing an objective measure of improvements in airflow after
a therapeutic intervention. However, assessments of dyspnea,
functional status, and overall heath status are required to
characterize response to treatment. The most widely used dis-
ease-specific health status questionnaire for patients with
obstructive lung disease is the SGRQ. This standardized
measure was designed to quantify the impact of disease of
chronic airflow limitation on health and well-being.18
SGRQ scores have been shown to have good repeatability
and correlate with a range of established measures of disease
activity, such as spirometry, 6-minute walking distance, mor-
tality, and the incidence of COPD exacerbations.18,19 The to-
tal mean SGRQ score of patients who underwent mediastinal
repositioning and who completed the questionnaire was 25.9
6 4.9 (Table E2). In a recent study evaluating the association
between health-related QOL and disease severity using the
Global Initiative for Chronic Obstructive Lung Disease
guidelines, a total SGRQ score of 25 corresponded to aGlobal
Initiative for Chronic Obstructive Lung Disease stage I,
which was characteristic of patients with mild COPD.20 An
SGRQ total score of 25.9 also compares favorably to patients
in the National Emphysema Treatment Trial. The baseline
SGRQ total score was 52.56 12.6 for patients in the surgical
arm of the National Emphysema Treatment Trial and 53.66
12.7 for patients randomized to medical therapy.21 The
results of the QOL assessment suggest that the clinical symp-
tomatic improvement in patients with postpneumonectomy
syndrome who undergo mediastinal repositioning is more
significant than can be quantified by pulmonary function
studies alone. Mediastinal repositioning provides significant
improvement in relief of symptoms and enables patients to
return to a high level of activity and good functional status.
Moreover, these improvements in overall and disease-
specific health-related QOL appear to be durable.
Conclusions
Although we still have no explanation from this study or
other reports why extreme mediastinal displacement and
rotation occur in a small subset of patients who undergo
pneumonectomy, once postpneumonectomy syndrome is
identified and becomes symptomatic, patients should un-
dergo prompt surgical correction. Mediastinal repositioning
and placement of saline-filled breast implants can be
performed with low morbidity and mortality, and provide
significant and durable symptomatic relief to patients with
postpneumonectomy syndrome.
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Discussion
Dr S. Murthy (Cleveland, Ohio). Dr Shen and colleagues have
provided a retrospective descriptive review of their experience of
the surgical management of a rare but devastating complication after
pneumonectomy. Although this a series of only 18 patients, it does
represent the largest report of its kind. It is unfortunate that the fol-
low-up of such a select group of patients is so incomplete, with only
13 of 17 patients who survived answering QOL questionnaires and
11 of 17 patients with full spirometric evaluation. Limited follow-up
in the context of such a small study can drastically bias the interpre-
tation of the results. To highlight this confound, the median length of
stay for the 11 patients with spirometry was almost double that of the
entire cohort at 11 days, and their mean length of stay was almost 40
days. Consequently, it is difficult for me to critically and meaningful
evaluate the findings. However, there are other aspects of the article2008
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TSthat are provocative and worthy of discussion, and I will direct my
attention to these.
I am intrigued by the operation and am impressed that such an
undertaking can be completed. Would you comment on the follow-
ing technical issues. How do you size the implants, and how are car-
diac hemodynamics measured intraoperatively and postoperatively
to prevent cardiac tamponade, ventricular arrhythmia, or decreased
venous return?
Dr Shen. The issue of how to size the implant is one that we be-
lieve is based in some ways on trial and error at the time of the op-
eration. After the pneumonectomy space has been opened and all of
the scar and adhesions have been mobilized to allow repositioning
of the herniated lung back to the proper side and repositioning
mediastinal structures, heart, and pericardium back to a central
position, we typically have used a technique where a measured
amount of saline is poured into the chest to be able to estimate the
volume of this often complex space. On the basis of the measured
volume of saline that is then removed from the chest, we then select
a number of breast implant sizers, test-sizers, before committing to
an actual implant. I think it also speaks to your second question on
how to monitor these patients postoperatively. Once the approxi-
mate volume has been selected, a critical technical point is that ex-
tensive monitoring of hemodynamics in terms of pulse, blood
pressure, and central venous pressure with central line monitoring
is important to be on the lookout for tamponade physiology. In ad-
dition, we use flexible bronchoscopy extensively throughout the
procedure once the mediastinal structures have been centrally lo-
cated, as well as after test placement of the implants and after the
chest has been closed. A final check once the patient has been turned
supine is also done. It’s worth noting that 4 of the 18 patients, after
partial closure of the chest, developed tamponade physiology and
had to have their partially closed incision reopened and the volume
adjusted. We also make use of intraoperative radiography with
a chest x-ray done at the end of the procedure, also looking for atel-
ectasis and overcorrection. So I think the issue of how to correctly
size the repositioning is intimately tied to the monitoring that’s
done in the procedure.
Dr Murthy. I have 2 other technical questions. Can you do this
extrapleurally? It seems like that might be an easier approach, not
having done one of these, but just thinking about it. Might tissue
expanders be a more appropriate choice to fill the space? This is
reported in the pediatric literature.
Dr Shen. The tasks that need to be achieved to successfully
reposition the mediastinum are that the scar and adhesions holding
the herniated lung, as well as the pericardium and other mediastinal
structures, need to be lysed and divided to allow one to centrally
reposition the mediastinum. Another important technical point to
emphasize is that the junction between the pneumonectomy stump
and the main bronchus needs to be extensively dissected and liber-
ated. That junction is oftentimes scarred to either the vertebral body
or the posterior mediastinum, and if you don’t achieve liberation and
complete lysis of that scar tissue there, you can still reposition the
mediastinal structures centrally, but if that tethering point hasn’t
been fully dissected, you’re still going to have mechanical compres-
sion of either the main or lobar bronchi and not achieve the desired
result. Whether or not that can be done easier from an extrapleural
approach, I don’t think so. To accomplish all those things, I think
it’s necessary to open the pneumonectomy space.The Journal of ThoraAs far as the issue of having adjustable tissue expanders, it has
been described extensively in the pediatric literature. I think that
for pediatric patients, to allow for further somatic growth, it is worth-
while to consider. In adult patients, it’s really not necessary. Several
other groups have reported the use of adjustable breast implants in
adults and have not found the need to make adjustments after
surgery.
Dr Murthy. I’ll skip to the last point. Finally, what might be the
mechanism for the apparent amelioration of this syndrome? Your
spirometry data actually argue against that you have solved
a functional airway obstruction. Other reports and my own common
sense would suggest that there would be an improvement in
spirometry measurements, especially FEV1, if a suspected airway
stenosis were to be relieved by your maneuvers. Perhaps it is the
relief of some intracardiac shunt or right atrial compression that
might lead to your improvement, and there is a syndrome, platyp-
nea-orthodeoxia, that has been reported as a possible putative mech-
anism for this kind of problem.
Dr Shen. We believe that there are 2 important physiologic
derangements that contribute to the overall syndrome. The first is
obviously a mechanical compression of the main bronchus or lobar
bronchus from the mediastinal shift, and so you get a functional and
a dynamic compressive upper airway obstruction. The second com-
ponent to the syndrome is due to the shift and herniation and over-
expansion of the residual lung. In patients with symptoms of
dyspnea and shortness of breath from this syndrome, I think it’s
a combination of these mechanisms, and each patient probably
has a mix of the effects of the overexpansion and herniation of the
lung, as well as the mechanical compression of the airway itself.
We believe that the relief that patients get from surgical correction
with mediastinal repositioning really comes from addressing both
of those issues independently. They are independent and also con-
nected. We did find in the spirometry data that the FVC decreased
in every patient, reflecting correction of the hyperexpansion. The
results with FEV1 have not been consistent. In Dr Grillo’s original
report, 7 patients had preoperative and postoperative spirometry,
4 patients had improvement in the FEV1, and 3 patients had decline.
In this current series of patients, 9 decreased and 2 increased. I think
the relief of dyspnea that patients get is probably a combination of
the correction of the overexpansion of the herniated lung and relief
of the mechanical obstruction on the airway. Depending on which
component of that is more important for any given patient, that’s
probably ultimately what affects the end result of relief of
symptoms.
Dr Murthy. That such a study could be done clearly demon-
strates the expertise of you and your group.
Dr J. Deslauriers (Quebec City, Quebec, Canada). What do
you think is the true incidence of this complication after pneumonec-
tomy?
Dr Shen. I think it’s extremely low. The only reported incidence
I’ve seen is an estimate of 1 in 640 pneumonectomies in children,
and obviously that’s much lower in adults.
Dr Deslauriers. So it would be extremely rare.
Dr Shen. Extremely rare.
Dr Deslauriers. Perhaps 1 in 1,000 or something like that?
Dr Shen. At least, yes.
Dr Deslauriers. My second question has to do with the some-
times associated bronchomalacia. This problem was mentioned incic and Cardiovascular Surgery c Volume 135, Number 6 1217
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of bronchial cartilages that may occur over time. Do you still just put
the intrapleural prosthesis, or do you do something else with the
bronchus to stabilize it?
Dr Shen.You raise an important point in the management of this
syndrome. It is difficult to determine which of these patients will
continue to have malacic changes in the airway after repositioning.
We typically do have these patients undergo awake bronchoscopy
so they can do provocative maneuvers. Sometimes you’re turning
them on their side. We look specifically at the time of bronchoscopy
to see if we can see the cartilaginous rings and dynamic change.
Even with all of those maneuvers, we have not been able to deter-
mine with any high degree of accuracy preoperatively which pa-
tients will continue to have malacia after successful repositioning.
In the original series of articles there were a number of things that
tried to address the malacia, including tracheal resection of that seg-
ment with reconstruction. Our current recommendation would be
that patients who have persistent malacic segments after reposition-
ing undergo prompt tracheal stenting.
Dr Deslauriers. So you just do the described operation, hoping
that the bronchus will be stabilized once the mediastinum is reposi-
tioned.
Dr Shen. Yes.
Dr Deslauriers. Do you perform a bronchoscopy while you’re
doing these procedures to see if the trachea has been repositioned
in the midline?
Dr Shen. Yes, absolutely. It’s one point I tried to stress with
some of the questions that Dr Murthy asked. It is an important
part of the technical conduct of the operation to be conducting flex-
ible bronchoscopy at multiple time points during the operation: once
the mediastinal structures have been repositioned into the central lo-
cation to assess how you’ve relieved the compression on the airway,
when the implants are placed, when you begin closing the chest, and
then, finally, again looking with a bronchoscope when the patients
are turned onto their back. In several of the cases in this series we
found that the patients had been overcorrected and required reopen-
ing the incision and removing some of the volume from their
implants.
Dr Deslauriers. Do these prostheses have a subcutaneous port
where you can aspirate fluid out if required?
Dr Shen. Yes there are implants with subcutaneous ports avail-
able.
Dr Deslauriers. So you don’t really need to reopen the chest.
Dr Shen. In 4 cases the chest had already been mostly closed,
and according to the intraoperative chest x-ray or bronchoscopy,
we found that they had actually been overcorrected, or they were
fine when they were in the lateral decubitus position. Then when
they were put supine again, they were overcorrected, and you
needed to be able to at least access the implants to remove some
volume. It would not be practical to routinely use the implants
with subcutaneous ports, because multiple implants are being placed
into the pneumonectomy space.
Dr Deslauriers. There were 3 patients in your series in whom
the pneumonectomy had been done for chronic lung disease, pre-
sumably for tuberculosis, or destroyed lung. Because these patients
usually already have their mediastinum shifted beforehand, why do
you think they developed this syndrome?
Dr Shen.Why was the mediastinum not fixed in those patients?1218 The Journal of Thoracic and Cardiovascular Surgery c JunDr Deslauriers. Well, usually it’s fixed, yes.
Dr Shen. The 3 patients who underwent operation for infectious
reasons had airway obstruction or were developing chronic pulmo-
nary infections. They were not necessarily patients who originally
underwent pneumonectomy for infectious causes, and because
they developed post-pneumonectomy syndrome I don’t think their
mediastinum was fixed before pneumonectomy.
Dr O. Adebo (Ibadan, Nigeria). I’m curious about the explana-
tion that you gave for the pathology. Most of the pneumonectomies
we do are for tuberculous destroyed lung, and at the end of the
pneumonectomy, the patient’s x-ray looks similar to that of patients
with postpneumonectomy syndrome, and they have no symptoms.
At the end of the pneumonectomy, the shift is as much, if not
more, than what you showed from your x-rays, and I’m curious
why those patients don’t seem to develop any respiratory problem
or symptoms despite the remarkable shift of the heart to the oper-
ated side, the pneumonectomized side, and we don’t make any ef-
fort, of course, to reposition it because the lungs are invariably
there already and the patient is well adjusted to it. So I’m wondering
why the explanation you gave would be the one to undermine this
syndrome.
Dr Shen. That’s an interesting observation. I don’t really have
a good explanation for why you don’t observe this syndrome in
those patients who essentially have a destroyed lung. Have you
ever seen this syndrome in patients who have undergone pneumo-
nectomy?
One of the continuing unanswered questions with this syndrome
is what are the predisposing factors, why is this such a rare syn-
drome, and are there factors that you could use to predict who is
more likely to develop this syndrome. We don’t really have any fur-
ther insight into that. It seems to be that this is more prevalent in
women and is more prevalent or more likely in patients who have
undergone right pneumonectomy. If we were to look at the total,
the 29 patients who were treated at Massachusetts General from
1979 to 2004, 22 of the 29 were women and 20 of the 29 patients
had a right pneumonectomy. But as to the real question, why do
some people get it and what are the predisposing factors, I think
we still don’t know.
DrW. Klepetko (Vienna, Austria). I would like to come back to
the importance of the hemodynamic component in the syndrome
that was stressed before. We recently identified a series of 5 or 6 pa-
tients in our patient cohort who developed severe postpneumonec-
tomy syndrome based on hemodynamic grounds either on the
reopening of the foramen ovale or on the compression of the right
atrium because of an unusually high elevation of the right dia-
phragm. These were all cases of right pneumonectomy. The leading
symptom in those patients was always severe hypoxemia, which
sometimes developed rapidly, and after the correction, either the clo-
sure of the intracardiac shunt or the repositioning of the diaphragm,
the hypoxemia was overcome and blood gases were pretty much
normalized.
What have you done to rule out such a hemodynamic compo-
nent? Could you give us some data on your blood gases, which
you did not show us. Were they impaired before the operation,
and how did they behave after the operation?
DrShen. I don’t have any data concerning preoperative and post-
operative blood gases to be able to share with you. In many of the
cases in this series that were evaluated, part of the preoperativee 2008
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tomy syndrome included echocardiography, and sometimes patients
also have transesophageal echo studies in the operating room.We are
looking specifically for alternative explanations for their symptoms.
Dr Klepetko. Have you seen in your large experience any pa-
tients with such a syndrome based on hemodynamic grounds only?
Dr Shen. No. There have been a couple of patients who contin-
ued to have similar symptoms after postpneumonectomy surgical re-
pair with repositioning and were found to have some cardiac issues
that were uncovered.
Dr T. Daniel (Charlottesville, Va). Congratulations, Dr Shen, on
an interesting presentation of this rare condition. I don’t know
whether operating on 3 additional patients makes me an expert,
but perhaps so. To suggest an answer to our colleague from Nigeria
as to causation, we looked at some of our patients and the patients in
Dr Grillo’s first report, and there seems to be a narrow interval be-The Journal of Thoratween the sternum and the anterior portion of the vertebral body
that may show up in that difference in the sex incidence. Most
womenmight have less of a barrel chest, and thismay be a predispos-
ing factor. Certainly for all the pneumonectomies done in the world,
why such a small handful get it, we don’t know, but that may be
a predisposing cause.
To Dr Deslauriers’ question as to why we don’t use the adjust-
able port to modify these patients, 1 of 3 patients had a problem
in the postoperative unit that required returning to the operating
room and taking some fluid out. We used a breast prosthesis with
an implantable port subcutaneously on the first patient and thought
we got a good result, but 6 months after operation, she apparently
had a stress fracture of the polyethylene catheter connecting the
prosthesis to the extrathoracic position and had a, quote, ‘‘flat
tire’’ and redeveloped the syndrome, and we reoperated on her
with a successful result. So that’s a factor you wouldn’t think of.cic and Cardiovascular Surgery c Volume 135, Number 6 1219
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TSFigure E1. Postpneumonectomy syn-
drome in a 20-year-old woman (patient
16) who underwent right pneumonec-
tomy for carcinoid 4 years earlier. She
developed postpneumonectomy syn-
drome within 1 year of pneumonectomy
and had mediastinal repositioning with
breast implants. Recurrent symptoms
developed after one of the implants rup-
tured. The patient underwent reopera-
tion with placement of Lucite balls. A,
Chest roentgenogram shows heart and
mediastinum displaced to the right
with obliteration of the right pleural
space. The lung is hyperexpanded and
herniated, and numerous plombage
balls can be seen. B, Lateral view dem-
onstrates posterior displacement of
mediastinal contents.1219.e1 The Journal of Thoracic and Cardiovascular Surgery c June 2008
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TSFigure E2. A, Computed tomography scan of the same patient shows shift of the mediastinum to the right and pos-
teriorly with compression of the left mainstem bronchus between the pulmonary artery and the aorta. B, Despite the
presence of numerous prostheses, the mediastinum is shifted into the pneumonectomy space.The Journal of Thoracic and Cardiovascular Surgery c Volume 135, Number 6 1219.e2
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Lucite plombage balls were removed from the pneumonectomy
space and replaced with saline-filled breast implants.1219.e3 The Journal of Thoracic and Cardiovascular Surgery c June 2008
Shen et al General Thoracic Surgery
G
TSFigure E4. Computed tomography scan after third corrective oper-
ation. Lung herniation has been corrected, and the mediastinum is
in the central position with the left main bronchus to the left of the
spine.The Journal of Thoracic and Cardiovascular Surgery c Volume 135, Number 6 1219.e4
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TSTABLE E1. Selected responses to Short Form-12 and St
George's Respiratory Questionnaire: Total respondents5 13
1. In general, would you say your health at present is:
Excellent 7.7%
Very good 46.2%
Good 38.5%
Fair 7.7%
Poor 0%
2. Compared with your condition before your operation,
how would you rate your health in general now?
Much better than before surgery 76.9%
Somewhat better 15.4%
About the same 7.7%
Somewhat worse 0%
Much worse 0%
3. Compared with your condition before surgery, was your
breathing better after operation?
Much better 76.9%
Somewhat better 15.4%
About the same 7.7%
Somewhat worse 0%
Much worse 0%
4. If your breathing was improved after your operation,
has it remained so?
Yes 100%
No 0%
5. During the past 4 weeks, to what extent have your physical or
emotional problems related to your breathing problems
interfered with your normal social activities with family,
friends, neighbors, or groups?
Extremely 0%
Quite a bit 0%
Moderately 8.3%
Slightly 25%
Not at all 67%
6. During the past 4 weeks, have you had to cut down on the
amount of time you spend on work or other activities as a
result of your physical health?
All of the time 0%
Most of the time 15.4%
Some of the time 0%
A little of the time 23.1%
None of the time 61.5%
7. During the past 4 weeks, have you accomplished less than you
would like as a result of your physical health?
All of the time 0%
Most of the time 23.1%
Some of the time 15.4%
A little of the time 7.7%
None of the time 53.9%
8. During the past 4 weeks, have been limited in the kind of work
or other activities as a result of your physical health?
All of the time 0%
Most of the time 7.7%
Some of the time 23.1%
A little of the time 30.8%
None of the time 38.5%1219.e5 The Journal of Thoracic and Cardiovascular Surgery cTABLE E1. Continued
9. During the past 4 weeks I have coughed
Almost every day 7.7%
Several days per week 0%
A few days per month 30.8%
Only with lung/respiratory infections 30.8%
Not at all 30.8%
10. During the past 4 weeks, I have brought up phlegm
Almost every day 0%
Several days per week 7.7%
A few days per month 23.1%
Only with lung/respiratory infections 7.7%
Not at all 61.5%
11. During the past 4 weeks, I have had shortness of breath
Almost every day 15.4%
Several days per week 15.4%
A few days per month 23.1%
Only with lung/respiratory infections 23.1%
Not at all 23.1%
12. During the past 4 weeks, I have had episodes of wheezing
Almost every day 0%
Several days per week 0%
A few days per month 15.4%
Only with lung/respiratory infections 38.5%
Not at all 46.2%
13. During the last 4 weeks how many severe or very unpleasant
episodes of lung/respiratory problems have you had?
More than 3 episodes 7.7%
3 episodes 7.7%
2 episodes 7.7%
1 episode 46.2%
No episodes 38.5%
14. During the last 4 weeks, in an average week, how many good
days (with few lung/respiratory problems) have you had?
None 0%
1 or 2 0%
3 or 47.7%
nearly every day 84.6%
all 7.7%
15. How would you describe your lung/respiratory condition?
The most important problem I have 7.7%
Causes me a lot of problems 0%
Causes me a few problems 69.2%
Causes me no problems 15.4%
16. Do you still have an audible wheeze?
Yes 23.1%
No 76.9%
17. Which of the following best describes how your breathing
problem affects you
It does not stop me from doing anything I would like to do 30.8%
It stops me from doing one or two things I would like to do 69.2%
It stops me from doing most of the things I would like to do 7.7%
It stops me from doing everything I would like to do 0%June 2008
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Patient No.
Symptoms
score
Activity
score
Impacts
score
Total
score
2 53.98 35.79 29.34 35.87
3 16.33 0.00 4.20 5.00
5 47.26 29.70 18.88 27.72
7 34.90 49.13 16.57 30.50
9 36.60 31.72 5.85 19.59
10 9.63 35.79 6.53 16.66
11 11.56 0.00 0.00 2.07
13 33.43 73.83 25.53 42.75
14 53.96 86.59 64.94 70.05
15 33.28 23.72 12.36 19.82
16 59.35 23.72 21.20 28.86
17 37.48 29.63 25.39 28.94
18 8.92 18.81 4.56 10.00
Mean 1 SE 25.9 1 4.9
SE, Standard error.The Journal of Thoracic and Cardiovascular Surgery c Volume 135, Number 6 1219.e6
